We are migrating the content of this website during the first semester of 2014 into the new EUR-Lex web-portal. We apologise if some content is out of date before the migration. We will publish all updates and corrections in the new version of the portal.
Do you have any questions? Contact us.
The purpose of this Decision is to set up a Pharmaceutical Committee to deal with problems arising in the field of proprietary medicinal products.
Council Decision 75/320/EEC of 20 May 1975 setting up a pharmaceutical committee.
The Decision sets up, and attaches to the Commission, a Pharmaceutical Committee composed of representatives from the Member States and chaired by a Commission representative. Each national representative is assisted by a deputy who is entitled to participate in meetings of the Committee.
The task of the Committee is to examine any question relating to proprietary medicinal products, in particular questions relating to the application of Directives on the subject, at the request of its Chairman or at the request of the representative of a Member State.
The Commission consults the Committee when preparing proposals for Directives.
There are other advisory committees used by the Commission when making decisions in the pharmaceutical field: the Veterinary Pharmaceutical Committee and the Telematics Committee.
|Act||Entry into force - Date of expiry||Deadline for transposition in the Member States||Official Journal|
|Decision 75/320/EEC||20.5.1975||-||OJ L 147, 9.6.1975|